These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 16227584)
1. Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum. Budagian V; Bulanova E; Orinska Z; Duitman E; Brandt K; Ludwig A; Hartmann D; Lemke G; Saftig P; Bulfone-Paus S Mol Cell Biol; 2005 Nov; 25(21):9324-39. PubMed ID: 16227584 [TBL] [Abstract][Full Text] [Related]
2. Axl is related to inflammation in hemodialysis patients. Li M; Xue W; Li X; Song Y; Liu X; Qin L Mol Immunol; 2021 May; 133():146-153. PubMed ID: 33667984 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions. Weinger JG; Omari KM; Marsden K; Raine CS; Shafit-Zagardo B Am J Pathol; 2009 Jul; 175(1):283-93. PubMed ID: 19541935 [TBL] [Abstract][Full Text] [Related]
4. Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE. Orme JJ; Du Y; Vanarsa K; Mayeux J; Li L; Mutwally A; Arriens C; Min S; Hutcheson J; Davis LS; Chong BF; Satterthwaite AB; Wu T; Mohan C Clin Immunol; 2016 Aug; 169():58-68. PubMed ID: 27237127 [TBL] [Abstract][Full Text] [Related]
5. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target. Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560 [TBL] [Abstract][Full Text] [Related]
6. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood. Ekman C; Stenhoff J; Dahlbäck B J Thromb Haemost; 2010 Apr; 8(4):838-44. PubMed ID: 20088931 [TBL] [Abstract][Full Text] [Related]
7. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Hundhausen C; Misztela D; Berkhout TA; Broadway N; Saftig P; Reiss K; Hartmann D; Fahrenholz F; Postina R; Matthews V; Kallen KJ; Rose-John S; Ludwig A Blood; 2003 Aug; 102(4):1186-95. PubMed ID: 12714508 [TBL] [Abstract][Full Text] [Related]
8. Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17). Budagian V; Bulanova E; Orinska Z; Ludwig A; Rose-John S; Saftig P; Borden EC; Bulfone-Paus S J Biol Chem; 2004 Sep; 279(39):40368-75. PubMed ID: 15215246 [TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl as markers of large abdominal aortic aneurysms. Ekman C; Site DF; Gottsäter A; Lindblad B; Dahlbäck B Clin Biochem; 2010 Jan; 43(1-2):110-4. PubMed ID: 19660445 [TBL] [Abstract][Full Text] [Related]
10. Induction of RAGE shedding by activation of G protein-coupled receptors. Metz VV; Kojro E; Rat D; Postina R PLoS One; 2012; 7(7):e41823. PubMed ID: 22860017 [TBL] [Abstract][Full Text] [Related]
11. Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Ludwig A; Hundhausen C; Lambert MH; Broadway N; Andrews RC; Bickett DM; Leesnitzer MA; Becherer JD Comb Chem High Throughput Screen; 2005 Mar; 8(2):161-71. PubMed ID: 15777180 [TBL] [Abstract][Full Text] [Related]
12. Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction. Caldentey G; García De Frutos P; Cristóbal H; Garabito M; Berruezo A; Bosch X; San Antonio R; Flores-Umanzor E; Perea RJ; De Caralt TM; Rodríguez J; Ortiz-Pérez JT Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):708-716. PubMed ID: 29119801 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival. Gustafsson A; Martuszewska D; Johansson M; Ekman C; Hafizi S; Ljungberg B; Dahlbäck B Clin Cancer Res; 2009 Jul; 15(14):4742-9. PubMed ID: 19567592 [TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes. Ekman C; Linder A; Akesson P; Dahlbäck B Crit Care; 2010; 14(4):R158. PubMed ID: 20731857 [TBL] [Abstract][Full Text] [Related]
15. Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway. Milosch N; Tanriöver G; Kundu A; Rami A; François JC; Baumkötter F; Weyer SW; Samanta A; Jäschke A; Brod F; Buchholz CJ; Kins S; Behl C; Müller UC; Kögel D Cell Death Dis; 2014 Aug; 5(8):e1391. PubMed ID: 25165877 [TBL] [Abstract][Full Text] [Related]
16. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Maretzky T; Schulte M; Ludwig A; Rose-John S; Blobel C; Hartmann D; Altevogt P; Saftig P; Reiss K Mol Cell Biol; 2005 Oct; 25(20):9040-53. PubMed ID: 16199880 [TBL] [Abstract][Full Text] [Related]
17. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. Abel S; Hundhausen C; Mentlein R; Schulte A; Berkhout TA; Broadway N; Hartmann D; Sedlacek R; Dietrich S; Muetze B; Schuster B; Kallen KJ; Saftig P; Rose-John S; Ludwig A J Immunol; 2004 May; 172(10):6362-72. PubMed ID: 15128827 [TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus. Ekman C; Jönsen A; Sturfelt G; Bengtsson AA; Dahlbäck B Rheumatology (Oxford); 2011 Jun; 50(6):1064-9. PubMed ID: 21278074 [TBL] [Abstract][Full Text] [Related]
19. Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism. Bakken AM; Protack CD; Roztocil E; Nicholl SM; Davies MG J Vasc Surg; 2009 May; 49(5):1296-303. PubMed ID: 19394555 [TBL] [Abstract][Full Text] [Related]
20. Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus. Liphaus BL; Lima L; Palmeira P; Silva CA; Goldenstein-Schainberg C; Carneiro-Sampaio M Clin Rheumatol; 2020 Feb; 39(2):509-514. PubMed ID: 31655933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]